Stuart Harris
Internal Medicine · Miami, FLNPI 1013315902
Payments from drug & device makers
Across 9 payments — averaging $68,145 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Assertio Therapeutics, Inc.$551K
- Eagle Pharmaceuticals, Inc.$62K
Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Assertio Therapeutics, Inc. | 8 | $551,294 |
| Eagle Pharmaceuticals, Inc. | 1 | $62,010 |
How this compares
$613,304 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 12 | $316 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Miami
- Mark KutnerMiami$35.7M
- Mercedes Ponce de LeonMiami$6.8M
- Alejandro de la CruzMiami$6.2M
- Roberto SotolongoMiami$5.8M
- Enrique PelayoMiami$5.4M
- Renato DominguezMiami$5.2M
- Ramses VegaMiami$4.4M
- Dunia Llapur HernandezMiami$4.3M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.